(Press-News.org) JACKSONVILLE, Fla. — A drug used to treat blood cancers may also stop the spread of invasive breast cancer, researchers at Mayo Clinic in Florida have discovered. Their study, published online in Breast Cancer Research, found that in the lab and in animals, the drug decitabine turns on a gene coding for protein kinase D1 (PRKD1) that halts the ability of cancer cells to separate from a tumor and spread to distant organs.
"Treatment with low doses of decitabine in an animal model of breast cancer restored PRKD1 expression, reduced tumor size, and blocked metastasis to the lung," says the study's senior investigator, Peter Storz, Ph.D., a biochemist and molecular biologist at Mayo Clinic in Florida.
"The outcome of patients with invasive breast cancer is less than optimal despite many attempts to improve treatment, including advanced chemotherapy and hormonal therapy," says Dr. Storz. "We hope this study offers a new avenue to prevent breast cancer from becoming aggressive and untreatable."
The research team, which includes first author Sahra Borges, Ph.D., a postdoctoral researcher in Dr. Storz's lab, found that the gene coding for PRKD1 was silenced in all but one subtype of invasive breast cancer, including aggressive triple negative breast cancer. That subtype is invasive lobular carcinoma.
Dr. Borges also developed an assay that can be used to measure the amount of PRKD1 that is silenced in patients' breast tumors.
"Because we found that PRKD1 is increasingly silenced as breast cancer becomes aggressive and spreads, the hope is that this test can be further developed and used to predict which patients are at risk for cancer metastasis, and thus may benefit from decitabine," Dr. Borges says.
Decitabine, approved by the U.S. Food and Drug Administration for use in some blood cancers, is a demethylating agent, meaning that it can switch on beneficial genes such as PRKD1 that cancer has silenced in order to grow.
Treating genes that are silenced is much easier than trying to restore function of a mutated gene, Dr. Storz says. The normal function of PRKD1, which is expressed in cells of the mammary gland, is to maintain normal function by preventing cells from morphing into a state where they can dislodge and spread, he says.
The researchers hope this study will help them to design a clinical trial in collaboration with Mayo Clinic physicians using decitabine to promote re-expression of PRKD1 and agents that activate PRKD1.
###
MULTIMEDIA ALERT: For audio and video of Sahra Borges, Ph.D., talking about the study, visit the Mayo Clinic News Network.
The study's other key researchers at Mayo include Heike Doeppler, Edith Perez, M.D., Cathy Andorfer, Ph.D., Zhifu Sun, M.D., Panos Anastasiadis, Ph.D., E. Aubrey Thompson, Ph.D., and Xochiquetzal J. Geiger, M.D. The study was supported by the National Institutes of Health (GM086435), the Bankhead-Coley Program of the Florida Department of Health, Mayo Clinic Breast Cancer SPORE, Breast Cancer Foundation, and from the 26.2 with Donna Foundation.
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit http://www.mayoclinic.com and http://www.mayoclinic.org/news.
Journalists can become a member of the Mayo Clinic News Network for the latest health, science and research news and access to video, audio, text and graphic elements that can be downloaded or embedded.
Drug used for blood cancers may stop spread of breast cancer cells, Mayo Clinic finds
2013-08-23
ELSE PRESS RELEASES FROM THIS DATE:
Protein-based urine test predicts kidney transplant outcomes
2013-08-23
Levels of a protein in the urine of kidney transplant recipients can distinguish those at low risk of developing kidney injury from those at high risk, a study suggests. The results also suggest that low levels of this protein, called CXCL9, can rule out rejection as a cause of kidney injury. The study appears online Aug. 22 in the American Journal of Transplantation. The work was funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
To prevent rejection, kidney transplant recipients typically take immunosuppressive ...
Astronomers use Hubble images for movies featuring space slinky
2013-08-23
Astronomers have assembled, from more than 13 years of observations from NASA's Hubble Space Telescope, a series of time-lapse movies showing a jet of superheated gas -- 5,000 light-years long -- as it is ejected from a supermassive black hole.
The movies promise to give astronomers a better understanding of how black holes shape galaxy evolution.
"Central, supermassive black holes are a key component in all big galaxies," said Eileen T. Meyer of the Space Telescope Science Institute in Baltimore, Md. "Most of these black holes are believed to have gone through an active ...
Researchers figure out why gold nanoparticles can penetrate cell walls
2013-08-23
CAMBRIDGE, Mass-- Cells are very good at protecting their precious contents — and as a result, it's very difficult to penetrate their membrane walls to deliver drugs, nutrients or biosensors without damaging or destroying the cell. One effective way of doing so, discovered in 2008, is to use nanoparticles of pure gold, coated with a thin layer of a special polymer. But nobody knew exactly why this combination worked so well, or how it made it through the cell wall.
Now, researchers at MIT and the Ecole Polytechnique de Lausanne in Switzerland have figured out how the ...
Computer simulations indicate calcium carbonate has a dense liquid phase
2013-08-23
Computer simulations conducted at the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab) could help scientists make sense of a recently observed and puzzling wrinkle in one of nature's most important chemical processes. It turns out that calcium carbonate—the ubiquitous compound that is a major component of seashells, limestone, concrete, antacids and myriad other naturally and industrially produced substances—may momentarily exist in liquid form as it crystallizes from solution.
Calcium carbonate is a huge player in the planet's carbon cycle, ...
A Pacific-wide satellite view catches Tropical Storm Pewa and a developing storm
2013-08-23
A view of the Pacific Ocean from NOAA's GOES-West satellite caught Tropical Storm Pewa moving through the Northwestern part of the ocean and two developing low pressure areas, one designated System 94E, several hundred miles off the Mexican coast.
NOAA's GOES-West satellite infrared imagery from today, Aug. 22 at 1200 UTC/8 a.m. EDT showed Tropical Storm Pewa heading west in the Northwestern Pacific. Pewa had a rounded circulation. The other two developing lows did not appear circular in the GOES-West image. The GOES image was created by the NASA GOES Project at NASA's ...
NASA catches Typhoon Trami's landfall in China
2013-08-23
NASA's Aqua satellite passed over Typhoon Trami during the time it was making landfall in eastern China and captured an infrared view of the storm.
Typhoon Trami made landfall late on Aug. 21, and the storm was captured in infrared light by the Atmospheric Infrared Sounder/AIRS instrument that flies aboard NASA's Aqua satellite. The AIRS image, taken on Aug. 21 at 17:59 UTC/1:59 p.m. EDT showed that the most powerful thunderstorms were tightly wrapped around the storm's center during landfall.
AIRS data also showed bands of powerful thunderstorms feeding into the center ...
Agricultural fires in central Africa
2013-08-23
The Moderate Resolution Imaging Spectroradiometer (MODIS) on NASA's Aqua satellite detected hundreds of fires burning in central Africa on August 21, 2013. The fires are outlined in red. Most of the fires burn in grass or cropland which is obscured by the smoke in this image.
The location, widespread nature, and number of fires suggest that these fires were deliberately set to manage land. Farmers often use fire to return nutrients to the soil and to clear the ground of unwanted plants. While fire helps enhance crops and grasses for pasture, the fires also produce smoke ...
Study adds lung damage to harmful effects of arsenic
2013-08-23
A new study confirms that exposure to low to moderate amounts of arsenic in drinking water can impair lung function. Doses of about 120 parts per billion of arsenic in well water—about 12 times the dose generally considered safe—produced lung damage comparable to decades of smoking tobacco. Smoking, especially by males, made arsenic-related damage even worse.
This is the first population-based study to clearly demonstrate significant impairment of lung function, in some cases extensive lung damage, associated with low to moderate arsenic exposure.
"Restrictive lung ...
UCLA Nursing study suggests focus on lifestyle changes -- not weight loss -- is key to kids' health
2013-08-23
A UCLA School of Nursing study has found that both healthy-weight and obese children who participated in an intensive lifestyle modification program significantly improved their metabolic and cardiovascular health despite little weight loss.
"These findings suggest that short-term lifestyle modifications through changing diet and exercise can have an immediate impact on improving risk factors such as cardiovascular disease and diabetes," said Christian Roberts, an associate research professor at the UCLA School of Nursing and the study's lead author. "This work underscores ...
Toxic nanoparticles might be entering human food supply
2013-08-23
COLUMBIA, Mo. – Over the last few years, the use of nanomaterials for water treatment, food packaging, pesticides, cosmetics and other industries has increased. For example, farmers have used silver nanoparticles as a pesticide because of their capability to suppress the growth of harmful organisms. However, a growing concern is that these particles could pose a potential health risk to humans and the environment. In a new study, researchers at the University of Missouri have developed a reliable method for detecting silver nanoparticles in fresh produce and other food ...